Study About Renal Profile In Patients Of Chronic Kidney Disease Undergoing Hemodialysis

Rabeea Mahmood, Siddiqa Ahmed Khan, Ayesha Mustafa

Abstract


The aim of this study is to analyze the levels of serum creatinine and blood urea nitrogen in patients of chronic kidney disease undergoing hemodialysis. Setting and DesignThe study design was observational cross-sectional based. Subject and Method85 patients suffering from chronic kidney disease were included in this study. Systematic Random Sampling technique was adopted. The data was analyzed using SPSS version 20. ConclusionsIn CRF patients, dialysis is the best method to remove accumulated nitrogenous end products from the body and improve the quality of life. But this may complicate the disease due to its side effects.  

The aim of this study is to analyze the levels of serum creatinine and blood urea nitrogen in patients of chronic kidney disease undergoing hemodialysis.

           

Setting and Design

The study design was observational cross-sectional based.

 

Subject and Method

85 patients suffering from chronic kidney disease were included in this study. Systematic Random Sampling technique was adopted. The data was analyzed using SPSS version 20.

 

Conclusions

In CRF patients, dialysis is the best method to remove accumulated nitrogenous end products from the body and improve the quality of life. But this may complicate the disease due to its side effects.

 

 


Full Text:

PDF

References


National Kidney Foundation. Kidney Disease Quality Outcomes Initiative (K/DOQI). http://www.kidney.org/professionals/kdoqi/guidelines.cfm (last accessed 2 June 2010). [Google Scholar]

Chertow GM. Slowing the progression of vascular calcification in hemodialysis. J Am Soc Nephrol 2003;14:S310–S314. [PubMed] [Google Scholar]

United States Renal Data System. 2009 Annual data report atlas of chronic kidney disease & end-stage renal disease in the United States. USRDS 2009. [Google Scholar]

Stel VS, Kramer A, Zoccali C, et al. The 2007 ERA-EDTA registry annual report - a precis. NDT Plus 2009;2:514–521. [PMC free article] [PubMed] [Google Scholar]

Australia and New Zealand Dialysis and Transplant Registry. 2008 Annual Report. ANZDATA 2008. [Google Scholar]

Buckalew VM Jr, Berg RL, Wang SR, et al. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 1996;28:811–821. [PubMed] [Google Scholar]

Hovind P, Rossing P, Tarnow L, et al. Progression of diabetic nephropathy. Kidney Int 2001;59:702–709. [PubMed] [Google Scholar]

Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995;123:754–762. [PubMed] [Google Scholar]

Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13–18. [PubMed] [Google Scholar]

Iseki K, Ikemiya Y, Iseki C, et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003;63:1468–1474. [PubMed] [Google Scholar]

Ansell D, Feest T, Calvani M. UK renal registry report 2002. Bristol, UK, 2002. [Google Scholar]

Perneger TV, Klag MJ, Whelton PK. Recreational drug use: a neglected risk factor for end-stage renal disease. Am J Kidney Dis 2001;38:49–56. [PubMed] [Google Scholar]

Perneger TV, Whelton PK, Klag MJ. Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Intern Med 1995;155:1201–1208. [PubMed] [Google Scholar]

Klag MJ, Whelton PK, Randall BL, et al. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997;277:1293–1298. [PubMed] [Google Scholar]

Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994;331:1675–1679. [PubMed] [Google Scholar]

Brancati FL, Whelton PK, Randall BL, et al. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 1997;278:2069–2074. [PubMed] [Google Scholar]

Orth SR, Stockmann A, Conradt C, et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998;54:926–931. [PubMed] [Google Scholar]

Orth SR. Smoking and the kidney. J Am Soc Nephrol 2002;13:1663–1672. [PubMed] [Google Scholar]

Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004;65:1870–1876. [PubMed] [Google Scholar]

Iseki K, Ikemiya Y, Inoue T, et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004;44:642–650. [PubMed] [Google Scholar]


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.